Home
Pharmacology

Filters

Found 1 Question

Set Default

Exams

INI CET

Subjects

Pharmacology

Topics

Microcytic anemia diagnosis (iron deficiency)
ACE inhibitors and renin-angiotensin system
Adrenal steroid inhibitors
Adverse Drug Reactions
Amphotericin B liposomal formulation
Amphotericin B toxicity
Anti-ageing drugs and molecular targets
Anti-estrogens and SERDs
Anti-glaucoma drugs - beta blockers
Anti-gout drugs - colchicine mechanism
Anti-osteoporotic drugs - Bisphosphonates
Antiarrhythmic drugs
Antiarrhythmics / QT prolongation
Antibiotics - bacteriostatic vs bactericidal
Anticancer Drugs
Anticholinergic effects and drug substitution in elderly
Anticoagulants
Anticoagulants (direct oral anticoagulants)
Anticoagulants (oral factor Xa inhibitors)
Antidiabetic Agents
Antiemetic drugs
Antiemetics - 5-HT3 antagonists
Antiepileptic teratogenicity
Antifungal agents
Antifungal drugs
Antigout drugs
Antihistaminics (H1 blockers)
Antihypertensives in CKD
Antimicrobial selection / Resistance
Antimicrobials - antibiotic sources
Antimicrobials / Mycoplasma
Antimuscarinic drugs / Peptic ulcer therapy
Antiparkinsonian drugs - COMT inhibitors
Antiplatelet drugs - prasugrel
Antiplatelet drugs - ticagrelor (P2Y12 inhibitor)
Antiprogestins
Antiprotozoal therapy - coccidia
Antipsychotic side effects
Antirheumatic drugs
Antitubercular drugs
Anxiolytics and serotonin receptors
Autacoids and their Antagonists
Autonomic Pharmacology and CNS Drugs
Beta thalassemia major pathophysiology
Beta-lactam resistance
CNS pharmacology - GABA-A receptor ligands
Caffeine — adenosine receptor antagonism
Cardiac glycosides and digitalis toxicity
Cardiac involvement in systemic sclerosis (myocardial fibrosis)
Cardiovascular system
Central Nervous system
Cephalosporins - adverse effects
Chemotherapy
Cholinergic drugs
Clinical Trials
Copper chelators in Wilson disease
Corticosteroids - hydrocortisone replacement dose
DMARDs in rheumatoid arthritis
Digoxin toxicity arrhythmias
Diuretics
Diuretics (site of action)
Diuretics and antihypertensives
Dose-response curve
Drug Overdose Treatment
Drug interactions
Drug metabolism - cytochrome P450
Drug safety in pregnancy
Drug therapy
Drug-induced hyperuricemia / gout
Drugs
Drugs acting on Respiratory system
Drugs for benign prostatic hyperplasia
Emergency contraception
Endocannabinoids / neurotransmitters
Fenfluramine adverse effects and monitoring
Fluoroquinolones
GLP-2 analog - short bowel syndrome
GPCR signalling - G-protein coupling of receptors
Gastrointestinal system
Gastrointestinal tract
General Pharmacology
Geriatrics - frailty and sarcopenia
Geriatrics - risk factors for falls in the elderly
H. pylori eradication
Heart failure drugs (ARNI)
Hematopoietic growth factors
Hemostasis
Histology special stains - liver fibrosis
Hormonal contraception - Progestin-only pills
Hormones
Hypolipidemic drugs (bile acid sequestrants)
Imatinib for GIST
Immunomodulators
Immunopharmacology
Injectable hormonal contraceptives
Inotropes and PDE-3 inhibitors
Insulin therapy in diabetes
Lapatinib dual HER1/HER2 inhibitor
Laxatives - anthranoid stimulants
Lepirudin for HIT
Linezolid toxicity monitoring
Lithium
Lithium drug interactions
Local Anaesthetics
Methotrexate urinary alkalinization
Methylxanthines
Migraine prophylaxis drugs
Movement disorders - chorea management
Mycophenolate mofetil adverse effects
NK1 antagonist antiemetics
NRTI adverse effects (didanosine)
Neuromuscular blocking agents
Nitric oxide signalling
Non-hormonal therapy for hot flushes
Opioid analgesics in day-care surgery
Opioid tolerance
Oral antidiabetics (biguanides)
Osteoporosis drugs - antiresorptive vs anabolic
Ototoxicity - aminoglycosides
PDE-5 inhibitors - nitrate interaction
Pharmacokinetics
Pharmacokinetics - drug ionisation and Henderson-Hasselbalch
Pharmacokinetics - plasma protein binding
Pharmacology of Endocrine system
Pharmacology of cardiovascular system
Pharmacology of central nervous System
Pharmacology of drug acting on the gastrointestinal tract
Pharmacology of peripheral nervous system
Posterior pituitary drugs - desmopressin
Potassium channel openers (antianginals)
Preterm labour and antenatal corticosteroids
Prokinetic drugs
Prostaglandins in obstetrics
Pulmonary arterial hypertension drugs
Receptor pharmacology
Receptor types / ligand-gated ion channels
Renin secretion control (RAAS)
Restless leg syndrome
Resuscitation - vasopressors
Serotonin syndrome management
Smoking cessation - nicotine replacement therapy
Smoking cessation agents
Sulphonamides classification
Targeted anticancer therapy - tyrosine kinase inhibitors
The respiratory system
Theophylline mechanism of action
Therapeutic index
Therapeutic index from quantal dose-response curve
Topical corticosteroid vehicles and potency
Toxicology
Toxicology and Antidotes
Tyrosine kinase inhibitors
Uterotonics in postpartum hemorrhage
Vasculitis classification by vessel size
Vasopressin analogues
Vitamins and Nutrition
Wilson disease and copper chelation therapy
antimicrobials
vitamins and minerals

List of top Pharmacology Questions on Microcytic anemia diagnosis (iron deficiency)

A patient has Hb 9 g/dL, MCV 68 fL and a low serum ferritin. The most likely type of anemia is:

INI CET - 2026
INI CET
Pharmacology
Microcytic anemia diagnosis (iron deficiency)

contact us

terms & conditions

Privacy & Policy